Frank Porreca

发表

Lead Development of SL-3111 ; Exploration of A Second Generation of Non-peptide Peptide Mimetics for Potent and Selective δ-Opioid Receptor Agonists

Toru Okayama, Hong-Bing Wei, Peg Davis, 2001 .

Afferent drive elicits ongoing pain in a model of advanced osteoarthritis

Jennifer Xie, Ping Liu, Jiyang Ren, 2012, PAIN®.

Lost but making progress—Where will new analgesic drugs come from?

David Borsook, Richard Hargreaves, D. Borsook, 2014, Science Translational Medicine.

Contribution of afferent pathways to nerve injury-induced spontaneous pain and evoked hypersensitivity

Jiyang Ren, T. King, F. Porreca, 2011, PAIN.

Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord

Anthony H. Dickenson, A. Dickenson, F. Porreca, 2014, Neuropharmacology.

Reversal of experimental neuropathic pain by T-type calcium channel blockers

F. Porreca, M. Ossipov, J. Lai, 2003, Pain.

Chronic pain and medullary descending facilitation

G. Gebhart, F. Porreca, M. Ossipov, 2002, Trends in Neurosciences.

Descending pain modulation and chronification of pain

F. Porreca, M. Ossipov, Kozo Morimura, 2014, Current opinion in supportive and palliative care.

A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain

Gerald W. Zamponi, David Parker, Hassan Pajouhesh, 2011, PAIN®.

Artemin induced functional recovery and reinnervation after partial nerve injury

T. King, F. Porreca, M. Ossipov, 2014, PAIN®.

The role of sodium channels in chronic inflammatory and neuropathic pain.

Peter Gerner, G. Bennett, M. Gold, 2006, The journal of pain : official journal of the American Pain Society.

Biocompatible PEDOT:Nafion composite electrode coatings for selective detection of neurotransmitters in vivo.

Michael L Heien, M. Heien, F. Porreca, 2015, Analytical chemistry.

Reward and motivation in pain and pain relief

E. Navratilova, F. Porreca, Frank Porreca, 2014, Nature Neuroscience.

Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats

F. Porreca, M. Ossipov, J. Lai, 1999, PAIN.

Lipid mediators regulating pain sensitivity.

F. Porreca, Frank Porreca, T. Malan, 2005, Prostaglandins & other lipid mediators.

Pain relief produces negative reinforcement through activation of mesolimbic reward–valuation circuitry

H. Fields, E. Navratilova, T. King, 2012, Proceedings of the National Academy of Sciences.

Probes for narcotic receptor mediated phenomena. 23.1 Synthesis, opioid receptor binding, and bioassay of the highly selective δ agonist (+)-4-[(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80) and related novel nonpeptide δ opioid receptor ligands

Robert Horvath, Judith L. Flippen-Anderson, Richard B. Rothman, 1997 .

Probes for Narcotic Receptor-Mediated Phenomena. 25.1 Synthesis and Evaluation of N-Alkyl-Substituted (α-Piperazinylbenzyl)benzamides as Novel, Highly Selective δ Opioid Receptor Agonists

Koichi Homma, Judith L. Flippen-Anderson, Richard B. Rothman, 1997 .

AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties

Mark H. Norman, J. Treanor, T. Vanderah, 2005, Journal of Pharmacology and Experimental Therapeutics.

Molecular Determinants of Vanilloid Sensitivity in TRPV1*

Attila Toth, Vellarkad N Viswanadhan, J. Treanor, 2004, Journal of Biological Chemistry.

Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8

M. Gold, F. Porreca, M. Ossipov, 2002, Pain.